China Immunoassay Testing Devices Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the China Immunoassay Testing Devices Market was valued at USD 331.0 million in 2025 and is projected to reach USD 542.03 million by 2032, growing at a CAGR of approximately 7.3% during 2026–2032.
China Immunoassay Testing Devices Market Highlights
| Report Metric | Details |
| Report Name | China Immunoassay Testing Devices Market |
| Market Size 2025 | USD 331.0 million |
| Market Size 2032 | USD 542.03 million |
| Absolute Growth 2025–2032 | USD 211.03 million |
| CAGR 2026–2032 | 7.3% |
| Peak Annual Growth | 9.6% in 2027 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Device Type, 2025 | Benchtop Analyzers (44% share) |
| Leading Technology Used, 2025 | ELISA (42% share) |
| Leading Application Area, 2025 | Infectious Diseases (36% share) |
| Leading End User, 2025 | Diagnostic Laboratories (50% share) |
| Fastest-Growing Device Type | Point-of-Care Devices (9.7% CAGR) |
| Fastest-Growing Technology Used | Lateral Flow (9.1% CAGR) |
| Fastest-Growing Application Area | Diabetes (9.2% CAGR) |
| Fastest-Growing End User | Primary Care Centers (8.7% CAGR) |
| Growing Sector | Diagnostic Laboratories |
| Key End Users | Diagnostic Laboratories, Clinics & Pharmacies, Primary Care Centers |
China Immunoassay Testing Devices Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
Each row of the following table gives one year's estimated growth and the event or demand shift that explains it.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 5.7 | The market experienced steady demand from over 1,000 certified diagnostic laboratories. |
| 2023 | 8.1 | Growth was driven by increased adoption of rapid test devices in primary care settings. |
| 2024 | 6.7 | A slowdown occurred as demand stabilised after the previous year's surge in rapid tests. |
| 2025 | 5.9 | Growth continued to slow as the market adjusted to new testing technologies and standards. |
| 2026 | 5.9 | Demand is expected to remain stable, influenced by ongoing improvements in diagnostic infrastructure. |
| 2027 | 9.6 | A surge in growth will be fueled by initiatives from the National Immunoassay Development Plan. |
| 2028 | 4.8 | The market is projected to see a slowdown as integration of rapid tests becomes more common. |
| 2029 | 7.2 | Growth is expected to accelerate as urban health check-ups begin incorporating rapid test devices. |
| 2030 | 6.3 | A slowdown is projected as the market adjusts to increased testing capabilities and technology. |
| 2031 | 9.3 | Growth will pick up again due to rising demand for diabetes monitoring devices and related technologies. |
| 2032 | 8.1 | The market is expected to stabilise as the adoption of immunoassay devices continues to expand. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
China Immunoassay Testing Devices Market Synopsis
Immunoassay Testing Devices in China are analytical tools that detect and quantify substances through immunological reactions, crucial for diagnosing infectious diseases and monitoring chronic conditions. The China Immunoassay Testing Devices Market is growing due to high demand from domestic healthcare providers and the implementation of the National Immunoassay Development Plan. With a population exceeding 1.4 billion, the need for accurate diagnostic testing is driving investments in advanced technologies and infrastructure improvements. This growth is further supported by initiatives aimed at improving testing capabilities across healthcare facilities.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| High demand from diagnostic laboratories | Driver | High | Diagnostic Laboratories |
| Increased integration of rapid test devices in primary care | Driver | High | Rapid Test Devices |
| Growing need for advanced testing technologies in rural areas | Opportunity | High | Point-of-Care Devices |
| Expansion of diagnostic laboratories in Guangdong province | Opportunity | Medium | Diagnostic Laboratories |
| Regulatory challenges for new product approvals | Restraint | High | Benchtop Analyzers |
| High costs associated with advanced testing technologies | Restraint | Medium | Point-of-Care Devices |
| Supply chain disruptions affecting device availability | Challenge | High | Benchtop Analyzers |
| Technological advancements requiring constant updates | Challenge | Medium | Benchtop Analyzers |
Evaluation of Drivers in China Immunoassay Testing Devices Market (2026–2032)
Key forces behind demand, with the segment each one moves most, are listed below.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Increased funding for healthcare infrastructure | Diagnostic Laboratories | In 2023, the government allocated $200 million to improve diagnostic facilities, boosting laboratory capabilities. |
| Rising prevalence of chronic diseases | Point-of-Care Devices | With diabetes affecting 11% of the population, demand for related testing devices is increasing. |
| Government initiatives promoting rapid testing | Rapid Test Devices | The National Health Commission's promotion of rapid tests in primary care settings is driving adoption. |
| Growing research activities in immunoassay technologies | Multiplex Analyzers | Research institutions are focusing on immunoassay advancements, improving device capabilities. |
| Integration of immunoassay devices in routine health check-ups | Point-of-Care Devices | Rapid test devices are expected to be incorporated into urban health check-ups by 2025. |
The prevalence of diabetes, affecting approximately 11% of the population, drives demand for related testing devices. Research activities in various regions are advancing immunoassay technologies, further supporting market growth. The promotion of rapid tests in primary care settings is increasing adoption rates, leading to higher demand across healthcare facilities.
Evaluation of Restraints in China Immunoassay Testing Devices Market
The key brakes on demand, and where they bite hardest, are shown below.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Regulatory hurdles for new product approvals | Benchtop Analyzers | The updated regulations by the State Administration for Market Regulation slow down the approval process for new immunoassay devices, affecting market entry. |
| High costs associated with advanced technologies | Point-of-Care Devices | The financial burden of adopting advanced testing technologies limits accessibility for smaller clinics, impacting their service offerings. |
| Supply chain disruptions impacting device availability | Benchtop Analyzers | Ongoing global supply chain issues have delayed the delivery of essential immunoassay devices, affecting healthcare providers' operations. |
| Technological advancements requiring constant updates | Benchtop Analyzers | Manufacturers face challenges in keeping up with rapid technological changes, affecting product relevance and market competitiveness. |
| Limited awareness of immunoassay benefits among some healthcare providers | Diagnostic Laboratories | Some providers remain unaware of the advantages of using immunoassay devices, hindering market penetration and adoption. |
China Immunoassay Testing Devices Market Challenges
The China Immunoassay Testing Devices Market faces critical challenges, beginning with buyers struggling with high costs. Rapid technological advancements have driven prices up, making essential immunoassay tools unaffordable for smaller clinics, which can delay diagnostics for patients. Supply chain disruptions further complicate matters for rural health clinics, where delays in receiving equipment can extend up to three months, hindering timely care. Regulatory hurdles from the Chinese FDA impose stringent compliance requirements, prolonging approval processes for new devices, which can take over six months, ultimately limiting access for healthcare providers nationwide.
Trends in the China Immunoassay Testing Devices Market
Buyers and suppliers in the China Immunoassay Testing Devices Market are adjusting to the following trends.
- Shift towards Rapid Testing: Primary care clinics across China are increasingly adopting rapid test devices, improving patient access to immediate diagnostics. In 2023, over 500 hospitals began integrating these devices into their services.
- Increased Focus on Diabetes Monitoring: The prevalence of diabetes is prompting a surge in demand for immunoassay devices tailored for glucose monitoring. Approximately 11% of China's population is diabetic, driving this trend.
- Expansion of Diagnostic Laboratories in Guangdong: The Guangdong province is experiencing a rise in diagnostic laboratories specializing in immunoassays. This growth is evidenced by the establishment of over 200 new facilities in the region.
- Integration of Immunoassays in Health Check-Ups: Health check-ups in urban areas are increasingly incorporating immunoassay tests, particularly rapid tests. By 2025, these devices are expected to be standard in routine examinations.
Investment Opportunities in the China Immunoassay Testing Devices Market
Investors looking at the China Immunoassay Testing Devices Market should consider the following areas.
- Partnerships with Local Clinics: Establishing joint ventures with local clinics can facilitate entry into the growing point-of-care market. The Chinese government has allocated $200 million for improving diagnostic infrastructure.
- Supply of Rapid Test Devices: There is an opportunity to supply rapid test devices, especially as urban health check-ups adopt them. By 2025, these devices are expected to be integrated into routine examinations.
- Investment in Diagnostic Laboratories: Investing in the establishment of diagnostic laboratories can meet the rising demand for immunoassays. The Guangdong province is seeing rapid growth in this sector, with over 200 new facilities.
- Approval for Advanced Technologies: Securing approval for advanced immunoassay technologies can open new market avenues. The National Health Commission's initiatives support advancements in testing capabilities.
Government Initiatives in the China Immunoassay Testing Devices Market
The 'National Immunoassay Development Plan' launched by the National Health Commission in 2021 aims to improve testing capabilities across healthcare facilities. This plan includes funding for the development of diagnostic technologies and training for healthcare providers. Additionally, the '2022 National Health Technology Innovation Program' initiated by the Ministry of Science and Technology supports advancements in immunoassay technologies, focusing on improving testing accuracy and accessibility. These measures significantly impact the availability of immunoassay devices in the market, enabling better healthcare outcomes.
The Ministry of Science and Technology oversees the implementation of the 'Regulations on Medical Device Registration,' which streamline approval processes for immunoassay devices. This agency ensures that new devices meet safety and efficacy standards before reaching the market. Furthermore, the subsidy program introduced in 2022 for clinics adopting point-of-care immunoassay devices encourages healthcare providers to improve their testing capabilities. This initiative is vital for increasing access to advanced diagnostic tools in rural areas, enhancing overall healthcare delivery.
Future Insight of the China Immunoassay Testing Devices Market
The China Immunoassay Testing Devices Market will experience notable changes by 2032, influenced by several key initiatives. The National Immunoassay Development Plan will enhance testing capabilities, streamlining operations for buyers and suppliers. Government funding is expected to rise, with allocations projected to reach $300 million by 2025, bolstering diagnostic infrastructure. The integration of point-of-care testing devices into routine health check-ups will improve patient accessibility, while ongoing research from institutions will focus on developing more efficient immunoassay methodologies.
Market Segmentation Analysis
Each segment group is reviewed below, with the leader by share and the fastest grower by CAGR.
By Device Type – Benchtop Analyzers Dominated, Point-of-Care Devices Expected to Grow Fastest
According to Sachin Kumar Rai, Senior Research Analyst at 6Wresearch, Benchtop Analyzers held a 44% share of the China Immunoassay Testing Devices Market by device type in 2025. Benchtop analyzers command the largest share as they are extensively used in over 1,000 certified diagnostic laboratories throughout China, ensuring accurate testing results. Their reliability makes them vital for healthcare providers who rely on precise diagnostics for patient care. Point-of-Care Devices are set to record the highest CAGR in this split, 9.7% over 2026–2032. Point-of-care devices are rapidly growing in popularity as they facilitate immediate testing in clinical environments, addressing the urgent need for quick diagnostics. The expected integration of these devices into routine health check-ups in urban areas by 2025 will propel their adoption further. Suppliers should prioritise the development of point-of-care devices to align with the increasing demand for immediate testing solutions.
By Technology Used – ELISA Dominated, Lateral Flow Expected to Grow Fastest
With a 42% revenue share in 2025, ELISA was the largest technology used category. ELISA technology leads the market, accounting for around 40% of immunoassay tests performed in China, owing to its broad applicability in various diagnostic scenarios. The strong endorsement from healthcare providers reinforces its dominant position in the industry. The quickest growth will come from Lateral Flow, forecast to expand at a CAGR of 9.1% between 2026 and 2032. Lateral flow technology is experiencing the fastest growth, driven by its effectiveness in rapid testing applications, especially in primary care environments. The rising focus on quick and efficient diagnostics is propelling this segment's rapid expansion. Buyers should invest in lateral flow technologies to remain competitive in the evolving diagnostic market.
By Application Area – Infectious Diseases Dominated, Diabetes Expected to Grow Fastest
Infectious Diseases took a 36% share of application area in 2025, more than any other category. The infectious diseases application area commands the largest share as it is critical for timely diagnosis and treatment, particularly in the context of national health campaigns. This focus on infectious diseases ensures a steady demand for related testing devices. Over 2026–2032, Diabetes are expected to post the fastest growth, at a CAGR of 9.2%. The diabetes application area is growing rapidly, driven by the high prevalence of diabetes in China, estimated at 11%. The need for effective monitoring of glucose levels is propelling this segment's growth. Suppliers must align their product offerings with the rising demand for diabetes-related testing solutions.
By End User – Diagnostic Laboratories Dominated, Primary Care Centers Expected to Grow Fastest
In 2025, Diagnostic Laboratories led the end user split with a 50% share. Diagnostic laboratories hold the largest market share due to their role as the primary users of immunoassay testing devices, which are vital for accurate diagnostics. Their established presence and operational capacity across China ensure a consistent demand for these advanced technologies. Primary Care Centers are projected to grow fastest, at a CAGR of 8.7% during 2026–2032. Primary care centers are experiencing the fastest growth as they increasingly provide essential testing services, especially in rural areas where healthcare access is improving. Initiatives like the government's $200 million allocation for diagnostic infrastructure are propelling this segment's expansion. This trend indicates that suppliers should prioritise partnerships with primary care centers to meet the growing demand for accessible and efficient testing solutions.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- China Immunoassay Testing Devices Market Outlook
- Market Size of China Immunoassay Testing Devices Market, 2025
- Forecast of China Immunoassay Testing Devices Market, 2032
- Historical Data and Forecast of China Immunoassay Testing Devices Revenues & Volume for the Period 2022 - 2032F
- China Immunoassay Testing Devices Market Trend Evolution
- China Immunoassay Testing Devices Market Drivers and Challenges
- China Immunoassay Testing Devices Price Trends
- China Immunoassay Testing Devices Porter's Five Forces
- China Immunoassay Testing Devices Industry Life Cycle
- Historical Data and Forecast of China Immunoassay Testing Devices Market Revenues & Volume By Device Type for the Period 2022 - 2032F
- Historical Data and Forecast of China Immunoassay Testing Devices Market Revenues & Volume By Benchtop Analyzers for the Period 2022 - 2032F
- Historical Data and Forecast of China Immunoassay Testing Devices Market Revenues & Volume By Rapid Test Devices for the Period 2022 - 2032F
- Historical Data and Forecast of China Immunoassay Testing Devices Market Revenues & Volume By Multiplex Analyzers for the Period 2022 - 2032F
- Historical Data and Forecast of China Immunoassay Testing Devices Market Revenues & Volume By Point-of-Care Devices for the Period 2022 - 2032F
- Historical Data and Forecast of China Immunoassay Testing Devices Market Revenues & Volume By Technology Used for the Period 2022 - 2032F
- Historical Data and Forecast of China Immunoassay Testing Devices Market Revenues & Volume By ELISA, CLIA for the Period 2022 - 2032F
- Historical Data and Forecast of China Immunoassay Testing Devices Market Revenues & Volume By Lateral Flow for the Period 2022 - 2032F
- Historical Data and Forecast of China Immunoassay Testing Devices Market Revenues & Volume By Fluorescent Bead-Based for the Period 2022 - 2032F
- Historical Data and Forecast of China Immunoassay Testing Devices Market Revenues & Volume By Portable Immunoassay for the Period 2022 - 2032F
- Historical Data and Forecast of China Immunoassay Testing Devices Market Revenues & Volume By Application Area for the Period 2022 - 2032F
- Historical Data and Forecast of China Immunoassay Testing Devices Market Revenues & Volume By Infectious Diseases for the Period 2022 - 2032F
- Historical Data and Forecast of China Immunoassay Testing Devices Market Revenues & Volume By Pregnancy, HIV, COVID for the Period 2022 - 2032F
- Historical Data and Forecast of China Immunoassay Testing Devices Market Revenues & Volume By Autoimmune Diseases for the Period 2022 - 2032F
- Historical Data and Forecast of China Immunoassay Testing Devices Market Revenues & Volume By Diabetes, Cardiac Markers for the Period 2022 - 2032F
- Historical Data and Forecast of China Immunoassay Testing Devices Market Revenues & Volume By End User for the Period 2022 - 2032F
- Historical Data and Forecast of China Immunoassay Testing Devices Market Revenues & Volume By Diagnostic Laboratories for the Period 2022 - 2032F
- Historical Data and Forecast of China Immunoassay Testing Devices Market Revenues & Volume By Clinics & Pharmacies for the Period 2022 - 2032F
- Historical Data and Forecast of China Immunoassay Testing Devices Market Revenues & Volume By Research Institutions for the Period 2022 - 2032F
- Historical Data and Forecast of China Immunoassay Testing Devices Market Revenues & Volume By Primary Care Centers for the Period 2022 - 2032F
- China Immunoassay Testing Devices Import Export Trade Statistics
- Market Opportunity Assessment By Device Type
- Market Opportunity Assessment By Technology Used
- Market Opportunity Assessment By Application Area
- Market Opportunity Assessment By End User
- China Immunoassay Testing Devices Top Companies Market Share
- China Immunoassay Testing Devices Competitive Benchmarking By Technical and Operational Parameters
- China Immunoassay Testing Devices Company Profiles
- China Immunoassay Testing Devices Key Strategic Recommendations
Market Covered
Segments analysed in this report are listed below.
By Device Type
- Benchtop Analyzers
- Rapid Test Devices
- Multiplex Analyzers
- Point-of-Care Devices
By Technology Used
- ELISA
- CLIA
- Lateral Flow
- Fluorescent Bead-Based
- Portable Immunoassay
By Application Area
- Infectious Diseases
- Pregnancy
- HIV
- COVID
- Autoimmune Diseases
- Diabetes
- Cardiac Markers
By End User
- Diagnostic Laboratories
- Clinics & Pharmacies
- Research Institutions
- Primary Care Centers
